Cel-Sci Corporation short interest in 2024
In 2024, Cel-Sci Corporation's disclosed short interest ran from 14.46% of shares outstanding on 12 Jan 2024 to 8.54% on 31 Dec 2024, a change of -5.92 percentage points. The year's high was 15.62% on 15 Jul 2024 and its low 6.96% on 30 Sep 2024, averaging 11.58% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 45.50 days on 30 Apr 2024. Full history: Cel-Sci Corporation.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 14.46% (12 Jan 2024)
- End of year
- 8.54% (31 Dec 2024)
- Change
- -5.92 pp
- High
- 15.62% (15 Jul 2024)
- Low
- 6.96% (30 Sep 2024)
- Average
- 11.58%
- Highest days to cover
- 45.50 (30 Apr 2024)
- SEC filings marked
- 3
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 14.46% | 26.92 | |
| 31 Jan 2024 | 14.73% | 33.19 | |
| 15 Feb 2024 | 14.52% | 19.24 | 10-Q filed |
| 29 Feb 2024 | 13.96% | 13.44 | |
| 15 Mar 2024 | 13.94% | 25.13 | |
| 28 Mar 2024 | 13.70% | 19.67 | |
| 15 Apr 2024 | 13.63% | 36.20 | |
| 30 Apr 2024 | 13.33% | 45.50 | |
| 15 May 2024 | 14.06% | 10.71 | 10-Q filed |
| 31 May 2024 | 14.61% | 29.68 | |
| 14 Jun 2024 | 14.84% | 37.51 | |
| 28 Jun 2024 | 15.16% | 29.16 | |
| 15 Jul 2024 | 15.62% | 36.91 | |
| 31 Jul 2024 | 12.59% | 1.24 | |
| 15 Aug 2024 | 7.64% | 8.69 | 10-Q filed |
| 30 Aug 2024 | 7.31% | 22.35 | |
| 13 Sep 2024 | 7.19% | 12.61 | |
| 30 Sep 2024 | 6.96% | 11.47 | |
| 15 Oct 2024 | 7.02% | 20.04 | |
| 31 Oct 2024 | 7.20% | 15.77 | |
| 15 Nov 2024 | 8.01% | 8.25 | |
| 29 Nov 2024 | 8.96% | 15.47 | |
| 13 Dec 2024 | 9.99% | 9.99 | |
| 31 Dec 2024 | 8.54% | 2.01 |
See also: Cel-Sci Corporation's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.